Importantly, programmed death-ligand 1 (PD-L1) was increased in the persisting symptom group compared to both convalescent and healthy control groups, consistent with previous reports, highlighting the prognostic role of sPD-L1 in COVID-19 patients [36] (Fig. 2g). The gene discussed is SPDL1; the disease is COVID-19.